Creutzfeldt-Jakob disease and blood transfusion-related risk in 1998

Authors
Citation
S. Laperche, Creutzfeldt-Jakob disease and blood transfusion-related risk in 1998, TRANSF CL B, 6(1), 1999, pp. 67-71
Citations number
10
Categorie Soggetti
Hematology
Journal title
TRANSFUSION CLINIQUE ET BIOLOGIQUE
ISSN journal
12467820 → ACNP
Volume
6
Issue
1
Year of publication
1999
Pages
67 - 71
Database
ISI
SICI code
1246-7820(199902)6:1<67:CDABTR>2.0.ZU;2-A
Abstract
As both iatrogenic and experimental transmission of Creutzfeldt-Jakob disea se (CJD) have been demonstrated, potential blood transfusion-related CJD th rough blood component contamination is not unlikely. Recent studies also su ggest that B lymphocytes would play a crucial role in the disease pathogene sis. However, to date, there is no epidemiological evidence suggesting that classical transmission of CJD would involve B lymphocytes. To reduce the t heoretical risk of such transmission and as no biological marker of the dis ease is currently available, at-risk blood donors are excluded and leukocyt e depletion has been introduced. Furthermore, the recent discovery of a new variant of the disease (nwCJD) which is caused by the bovine agent and has typical tropism for lymphoreticular tissues should lead to close surveilla nce. (C) 1999 Elsevier, Paris.